Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-006524 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-03-03 | MIRM | Peetz Christopher | CEO, Dir | S - Sale+OE | $46.91 | -40.0K | 115.9K | -26% | -$1.88M |
| D | 2025-03-04 | 2025-03-03 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $2.94 | +40.0K | 155.9K | +35% | +$117.6K |
| D | 2025-03-04 | 2025-03-03 | MIRM | Peetz Christopher | CEO, Dir | M - OptEx | $0.00 | -40.0K | 238.5K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 19,392 | $46.61 | 136,528 | D | — | — | (F2) The weighted average sale price for the transaction reported was $46.61, and the range of prices were between $45.82 and $46.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-03-03 | M | A | 40,000 | $2.94 | 155,920 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-03 | S | D | 20,608 | $47.19 | 115,920 | D | — | — | (F3) The weighted average sale price for the transaction reported was $47.19, and the range of prices were between $46.82 and $47.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | M | D | 40,000 | $0.00 | 238,487 | D | $2.94 · — to 2029-03-11 | 40,000 Common Stock | (F4) The stock option is fully vested. |